Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.63 |
| ▸ | ECE1 | P42892 | 1/20 | 0.38 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.38 |
| ▸ | GHSR | Q92847 | 1/20 | 0.38 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.36 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.36 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.36 |
| ▸ | GNPAT | O15228 | 1/20 | 0.36 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.36 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.36 |
| ▸ | CALCRL | Q16602 | 2/20 | 0.35 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.35 |
| ▸ | DHFR | P00374 | 1/20 | 0.35 |
| ▸ | FPGS | Q05932 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2243002 | 1.00 | SLC15A2 (0.63) | SLC15A2ECE1FOLH1GHSRSLC6A5 | |
| SCHEMBL2815080 | 1.00 | SLC15A2 (0.63) | SLC15A2ECE1FOLH1GHSRSLC6A5 | |
| SCHEMBL10595108 | 0.99 | SLC15A2 (0.64) | SLC15A2ECE1FOLH1GHSRSLC6A5 | |
| SCHEMBL5598418 | 0.99 | SLC15A2 (0.64) | SLC15A2ECE1FOLH1GHSRSLC6A5 | |
| SCHEMBL259084 | 0.99 | SLC15A2 (0.64) | SLC15A2ECE1FOLH1GHSRSLC6A5 | |
| SCHEMBL8832939 | 0.99 | SLC15A2 (0.64) | SLC15A2ECE1FOLH1GHSRSLC6A5 | |
| SCHEMBL259085 | 0.99 | SLC15A2 (0.64) | SLC15A2ECE1FOLH1GHSRSLC6A5 | |
| SCHEMBL4589314 | 0.98 | SLC15A2 (0.63) | SLC15A2ECE1FOLH1GHSRSLC6A5 | |
| SCHEMBL29767981 | 0.98 | SLC15A2 (0.63) | SLC15A2ECE1FOLH1GHSRSLC6A5 | |
| SCHEMBL4589903 | 0.98 | SLC15A2 (0.63) | SLC15A2ECE1FOLH1GHSRSLC6A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250381240-A1 | COMPOSITIONS AND METHODS FOR HAIR TREATMENT | NEUVIAN SKINCARE LLC (US) | 2025-12-18 | — | — | US | claimed |
| US-20250339545-A1 | ANTIOXIDANT COMPOSITIONS AND METHODS | LEUVIAN LLC (US) | 2025-11-06 | — | — | US | claimed |
| US-20250281563-A1 | COMPOSITIONS AND METHODS FOR HAIR TREATMENT | NEUVIAN IP HOLDINGS, LLC | 2025-09-11 | — | — | US | claimed |
| US-12409204-B1 | Compositions and methods for hair treatment | NEUVIAN IP HOLDINGS, LLC (US) | 2025-09-09 | — | — | US | claimed |
| US-12377156-B2 | Compositions and methods for treatment of wounds and inflammatory skin conditions | NEUVIAN IP HOLDINGS, LLC (US) | 2025-08-05 | — | — | US | claimed |
| WO-2025090117-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF WOUNDS AND INFLAMMATORY SKIN CONDITIONS | LEUVIAN, LLC (US) | 2025-05-01 | — | — | WO | claimed |
| US-20250127911-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF WOUNDS AND INFLAMMATORY SKIN CONDITIONS | NEUVIAN IP HOLDINGS, LLC | 2025-04-24 | — | — | US | claimed |
| US-11464727-B2 | Reduced-cost cosmetic formulations that reduce visible signs of ageing | SERENDIPITY TECHNOLOGIES LLC (US) | 2022-10-11 | — | — | US | claimed |
| US-20250381240-A1 | COMPOSITIONS AND METHODS FOR HAIR TREATMENT | NEUVIAN SKINCARE LLC (US) | 2025-12-18 | — | — | US | disclosed |
| US-20250339545-A1 | ANTIOXIDANT COMPOSITIONS AND METHODS | LEUVIAN LLC (US) | 2025-11-06 | — | — | US | disclosed |
| US-20250281563-A1 | COMPOSITIONS AND METHODS FOR HAIR TREATMENT | NEUVIAN IP HOLDINGS, LLC | 2025-09-11 | — | — | US | disclosed |
| US-12409204-B1 | Compositions and methods for hair treatment | NEUVIAN IP HOLDINGS, LLC (US) | 2025-09-09 | — | — | US | disclosed |
| US-12377156-B2 | Compositions and methods for treatment of wounds and inflammatory skin conditions | NEUVIAN IP HOLDINGS, LLC (US) | 2025-08-05 | — | — | US | disclosed |
| WO-2025090117-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF WOUNDS AND INFLAMMATORY SKIN CONDITIONS | LEUVIAN, LLC (US) | 2025-05-01 | — | — | WO | disclosed |
| WO-2003030860-A1 | SKIN CARE COMPOSITIONS CONTAINING PEPTIDE COPPER COMPLEXES AND RETINOL, RETINOL DERIVATIVES, OR A MIXTURE THEREOF | PROCYTE CORPORATION (US) | 2003-04-17 | — | — | WO | disclosed |
| WO-2003030926-A1 | STABLE SOLUTIONS OF PEPTIDE COPPER COMPLEXES AND COSMETIC AND PHARMACEUTICAL FORMULATIONS PRODUCED THEREFROM | PROCYTE CORPORATION (US) | 2003-04-17 | — | — | WO | disclosed |
| US-5977428-A | Absorbent hydrogel particles and use thereof in wound dressings | PROCYTE CORPORATION (US) | 1999-11-02 | — | — | US | disclosed |
| EP-0946216-A2 | ABSORBENT HYDROGEL PARTICLES AND USE THEREOF IN WOUND DRESSINGS | PROCYTE CORPORATION (US) | 1999-10-06 | — | — | EP | disclosed |
| WO-1998028013-A2 | ABSORBENT HYDROGEL PARTICLES AND USE THEREOF IN WOUND DRESSINGS | PROCYTE CORPORATION (US) | 1998-07-02 | — | — | WO | disclosed |
| WO-1994018230-A1 | INHIBITION OF HIV REPLICATION BY PEPTIDE-COPPER COMPLEXES | PROCYTE CORPORATION (US) | 1994-08-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12409204-B1 | Compositions and methods for hair treatment | AOC1, SOD3, OAT | SLC15A2 2188/4885ECE1 3790/4885FOLH1 189/4885 |
| US-12377156-B2 | Compositions and methods for treatment of wounds and inflammatory skin conditions | SOD3, SOD1, CUTA | SLC15A2 3194/4885ECE1 1269/4885FOLH1 1803/4885 |
| US-20250127911-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF WOUNDS AND INFLAMMATORY SKIN CONDITIONS | SOD3, SOD1, CUTA | SLC15A2 3194/4885ECE1 1269/4885FOLH1 1803/4885 |
| US-20250339545-A1 | ANTIOXIDANT COMPOSITIONS AND METHODS | SOD1, SOD3, LPO | SLC15A2 2852/4885ECE1 1454/4885FOLH1 2085/4885 |
| US-20250281563-A1 | COMPOSITIONS AND METHODS FOR HAIR TREATMENT | AOC1, SOD3, OAT | SLC15A2 2188/4885ECE1 3790/4885FOLH1 189/4885 |
| US-20250381240-A1 | COMPOSITIONS AND METHODS FOR HAIR TREATMENT | AOC1, SOD3, OAT | SLC15A2 2188/4885ECE1 3790/4885FOLH1 189/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.